Publications found:
400
Sort by:
Exosome Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Exosome Type (Natural, Hybrid), By Source (Mesenchymal Stem Cells, Blood, Body Fluids, Others), By Therapy (Immunotherapy, Chemotherapy, Gene Therapy), By Application (Metabolic Disorders, Oncology, Cardiac Disorders, Neurology, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Exosome Therapeutics Market, valued at USD 32.63 Million in 2024, is projected to experience a CAGR of 41.56% to reach USD 262.58 Million by 2030. Exosome therapeutics involve the utilizati...
November 2025
180 pages
T-cell Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy Type (CAR T-cell Therapy, T Cell Receptor (TCR)-based, Tumor Infiltrating Lymphocytes (TIL)-based)), By Indication (Hematologic Malignancies, Solid Tumors, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global T-cell Therapy Market, valued at USD 2.92 Billion in 2024, is projected to experience a CAGR of 9.90% to reach USD 5.14 Billion by 2030. T-cell therapy represents a specialized form of immu...
November 2025
183 pages
Nanobodies Market - Global Industry Size, Share, Trends, Opportunity and Forecast, By Type (Mono-Specific, Multi-Specific) By Application (Acquired Thrombotic Thrombocytopenic Purpura (TTP), Respiratory Syncytial Virus Infection, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Oncology, Psoriasis, Chronic Kidney Diseases, Bone Disorders, Others) By End User (Pharmaceutical & Biotechnology Companies, Research Laboratories, and Others), By Region, By Competition, 2020-2030F
US$ 4,500.00
The Global Nanobodies Market, valued at USD 578.40 Million in 2024, is projected to experience a CAGR of 18.30% to reach USD 1585.39 Million by 2030. Nanobodies, also known as single-domain antibodies...
November 2025
183 pages
CAR-T Cell Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Yescarta (Axicabtagene Ciloleucel), Kymriah (Tisagenlecleucel), Tecartus (Brexucabtagene Autoleucel), Breyanzi (Lisocabtagene Maraleucel), Abecma (Idecabtagene Vicleucel), Others), By Tumor Type (Hematological Malignancies, Solid Tumors), By Indication (Diffused Large B-Cell Lymphoma (DLBCL), Acute Lymphoblastic Leukemia (ALL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Others), By Treatment Type (Single Treatment, Combination Treatment), By Targeted Antigen (CD 19, BCMA (B-Cell Maturation Antigen), Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global CAR-T Cell Therapy Market, valued at USD 3.87 Billion in 2024, is projected to experience a CAGR of 22.77% to reach USD 13.25 Billion by 2030. Chimeric Antigen Receptor (CAR)-T cell therapy...
November 2025
182 pages
Human Albumin Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application [Therapeutic Applications (Liver and Kidney Diseases, Surgery, Hypovolemia and Hypoalbuminemia, and Others), Drug Delivery, Disease Diagnostics, Research, and Others], and End User (Hospitals and Clinics, Pharmaceutical and Biotechnological Companies, Research Institutes, Diagnostic Laboratories, Homecare Settings, and Others)
US$ 4,450.00
According to our new research study on “Human Albumin Market Forecast to 2031 -Global Analysis - by Application and End User,” the market is anticipated to grow from US$ 4.68 billion in 2024 to US$ 6....
November 2025
260 pages
Cardiovascular Biologics Market - 2025-2033
US$ 3,400.00
Cardiovascular Biologics Market reached US$ 2.20 Billion in 2024 and is expected to reach US$ 4.23 Billion by 2033, growing with a CAGR of 7.50% during the forecast period 2026-2033. The Cardiovascula...
November 2025
50 pages
Antibody Drug Conjugates Market Size, Share & Trends Analysis Report By Application (Blood Cancer, Urothelial Carcinoma, Ovarian Cancer, Breast Cancer, Other Cancer), By Product, By Payload, By Technology, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global antibody drug conjugates market size was estimated at USD 12.26 billion in 2024 and is projected to reach USD 32.11 billion by 2033, growing at a CAGR of 10.49% from 2025 to 2033. This grow...
November 2025
150 pages
U.S. Biologics Contract Development Market Size, Share, & Trends Analysis Report By Source (Mammalian, Microbial), By Product Service (Cell-line Development, Process Development), By Indication, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The U.S. biologics contract development market size was estimated at USD 2.82 billion in 2024 and is projected to reach USD 4.48 billion by 2033, growing at a CAGR of 5.3% from 2025 to 2033. Factors s...
October 2025
100 pages
Global Biological Drugs Market Growth 2025-2031
US$ 3,660.00
The global Biological Drugs market size is predicted to grow from US$ 357780 million in 2025 to US$ 583920 million in 2031; it is expected to grow at a CAGR of 8.5% from 2025 to 2031. The impact of th...
October 2025
115 pages
Global Biologics Market - 2025 -2033
US$ 4,350.00
Global Biologics Market: Industry Outlook The global biologics market reached US$ 472.71 billion in 2023, with a rise of US$ 512.25 billion in 2024, and is expected to reach US$ 966.98 billion by 2033...
October 2025
180 pages
Global Biologics Outsourcing Market - 2025 -2033
US$ 4,350.00
Global Biologics Outsourcing Market: Industry Outlook The global biologics outsourcing market reached US$ 20.10 billion in 2023, with a rise of US$ 22.92 billion in 2024, and is expected to reach US$...
October 2025
180 pages
Global Bispecific Mabs Market - 2025 -2033
US$ 4,350.00
Bi-Specific MAbs Market Size& Industry Outlook The global Bi-Specific MAbs market size reached US$ 4.82Billion with rise of US$5.51Billion in 2024 is expected to reach US$ 15.43 Billion by 2033, growi...
October 2025
180 pages
Global Multispecific Antibodies Market - 2025 -2033
US$ 4,350.00
Multispecific Antibodies Market Size The global multispecific antibodies market size reached US$ 12.61 Billion in 2024 from US$ 10.19 billion in 2023 and is expected to reach US$ 98.45 Billion by 2033...
October 2025
180 pages
Protein Therapeutics Market - 2025-2033
US$ 3,400.00
Protein Therapeutics Marketis is growing with a CAGR of 6.60% during the forecast period 2026-2035. The Protein Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth analysi...
September 2025
46 pages
Biologics & Biosimilars Market Forecasts to 2032 – Global Analysis By Product Type (Biologics, Biosimilars), Therapeutic Area (Oncology, Ophthalmology, Autoimmune Disorders, Cardiovascular, Endocrinology, Infectious Diseases, Hematology, and Wound Healing & Regenerative Care), Manufacturing Source, Distribution Channel, End User, and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Biologics & Biosimilars Market is accounted for $538.20 billion in 2025 and is expected to reach $1219.86 billion by 2032 growing at a CAGR of 12.4% during the...
September 2025
200 pages
Biologics Market Size, Share, Trends and Forecast by Source, Product, Disease, Manufacturing, and Region, 2025-2033
US$ 2,999.00
The global biologics market size was valued at USD 377.6 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 769.7 Billion by 2033, exhibiting a CAGR of 7.38% from 2025-203...
September 2025
149 pages
Immunology & Inflammatory Diseases Drugs Market - 2025-2033
US$ 3,400.00
Immunology & Inflammatory Diseases Drugs Market reached US$ 212.76 Billion in 2024 and is expected to reach US$ 431.11 Billion by 2033, growing with a CAGR of 8.20% during the forecast period 2026-203...
August 2025
66 pages
Janus Kinase (JAK) Inhibitors Market - 2025-2033
US$ 3,400.00
Janus Kinase (JAK) Inhibitors Market reached US$ 15.56 billion in 2024 and is expected to reach US$ 30.65 billion by 2033, growing with a CAGR of 6.80% during the forecast period 2026-2033. The Janus...
July 2025
55 pages
U.S. Anti-Venom Market Size, Share & Trends Analysis Report By Species (Snake, Scorpion, Spider), By Type (Polyvalent, Monovalent), By Mode of Action (Cytotoxic, Neurotoxic), By End Use, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 2 Business Days U.S. Anti-Venom Market The U.S. anti-venom market size was estimated at USD 424.5 million in 2024 and is projected to reach USD 670...
July 2025
80 pages
Humira Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Branded, Biosimilar), By Application (Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Crohn’s Disease (CD), Ulcerative Colitis (UC), Ankylosing Spondylitis, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview The Global Humira Market was valued at USD 10.41 Billion in 2024 and is projected to reach USD 19.84 Billion by 2030, growing at a CAGR of 11.32% during the forecast period. The market...
July 2025
184 pages
Adalimumab Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Biologics, Biosimilars), By Therapeutic Area (Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis, Crohn’s Disease, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview The Global Adalimumab Market was valued at USD 2.72 billion in 2024 and is anticipated to reach USD 3.56 billion by 2030, growing at a CAGR of 4.80% over the forecast period. Adalimuma...
June 2025
185 pages
Global Enzyme Replacement Therapy Market - 2025-2032
US$ 3,400.00
Global Enzyme Replacement Therapy Market reached US$11.05 billion in 2024 and, growing with a CAGR of 8.70% during the forecast period 2024-2035. The Global Enzyme Replacement Therapy Market emerges a...
June 2025
59 pages
Asia Pacific Biologics Market Forecast to 2031 - Regional Analysis - by Product (Monoclonal Antibodies, Vaccine, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), and Manufacturing (Outsourced and In-house)
US$ 3,450.00
The Asia Pacific biologics market was valued at US$ 1,01,590.5 million in 2023 and is expected to reach US$ 4,17,082.9 million by 2031; it is estimated to register a CAGR of 19.3% from 2023 to 2031. E...
April 2025
163 pages
Europe Biologics Market Forecast to 2031 - Regional Analysis - by Product (Monoclonal Antibodies, Vaccine, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), and Manufacturing (Outsourced and In-house)
US$ 3,450.00
The Europe biologics market was valued at US$ 1,15,057.6 million in 2023 and is expected to reach US$ 4,15,468.4 million by 2031; it is estimated to register a CAGR of 17.4% from 2023 to 2031. Prefere...
April 2025
162 pages
Middle East & Africa Biologics Market Forecast to 2031 - Regional Analysis - by Product (Monoclonal Antibodies, Vaccine, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), and Manufacturing (Outsourced and In-house)
US$ 3,450.00
The Middle East & Africa biologics market was valued at US$ 5,818.6 million in 2023 and is expected to reach US$ 17,939.1 million by 2031; it is estimated to register a CAGR of 15.1% from 2023 to 2031...
April 2025
153 pages
North America Biologics Market Forecast to 2031 - Regional Analysis - by Product (Monoclonal Antibodies, Vaccine, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), and Manufacturing (Outsourced and In-house)
US$ 3,450.00
The North America biologics market was valued at US$ 230,256.1 million in 2023 and is expected to reach US$ 888,880.0 million by 2031; it is estimated to register a CAGR of 18.4% from 2023 to 2031. In...
April 2025
146 pages
South & Central America Biologics Market Forecast to 2031 - Regional Analysis - by Product (Monoclonal Antibodies, Vaccine, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), and Manufacturing (Outsourced and In-house)
US$ 3,450.00
The South & Central America biologics market was valued at US$ 16,517.2 million in 2023 and is expected to reach US$ 54,534.7 million by 2031; it is estimated to register a CAGR of 16.1% from 2023 to...
April 2025
139 pages
Immunoglobulins Market Size, Share, and Analysis, By Product Type (IgG, IgA, IgM, IgD, IgE, and Others), By Route of Administration (Intravenous (IVIG), Subcutaneous (SCIg), and Others), By Application (Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Multifocal Motor Neuropathy (MMN), Primary Immunodeficiency Disease (PID), Secondary Immunodeficiency Disease (SID), Guillain-Barre syndrome, Immune thrombocytopenic purpura (ITP), and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
US$ 5,250.00
Immunoglobulins Market Size, Share, and Analysis, By Product Type (IgG, IgA, IgM, IgD, IgE, and Others), By Route of Administration (Intravenous (IVIG), Subcutaneous (SCIg), and Others), By Applicatio...
February 2025
571 pages
Autologous Stem Cell & Non-stem Cell Therapies Market Size, Share, and Analysis, By Type (Autologous Stem Cell Therapies and Autologous Non-stem Cell Therapies), By Application (Cancer Indications, Musculoskeletal Indications, Dermatological Indications, and Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Research Facilities, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
US$ 5,250.00
Autologous Stem Cell & Non-stem Cell Therapies Market is projected to exhibit a Compound Annual Growth Rate (CAGR) of 21% during the forecast span from 2024 to 2034. In 2023, the market size was asses...
January 2025
571 pages
Cell Therapy CDMO Market Size, Share, and Analysis, By Type (Stem Cell and Non-Stem Cell), By Application (Commercial and Academic Research), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
US$ 5,250.00
Cell Therapy CDMO Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 22.7% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 5.9 billion an...
January 2025
411 pages
